Andreas Harsch

756 total citations
16 papers, 345 citations indexed

About

Andreas Harsch is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Andreas Harsch has authored 16 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Andreas Harsch's work include DNA and Nucleic Acid Chemistry (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Andreas Harsch is often cited by papers focused on DNA and Nucleic Acid Chemistry (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Andreas Harsch collaborates with scholars based in United States and Bangladesh. Andreas Harsch's co-authors include Paul Vouros, Christine L. Andrews, Sujal V. Deshmukh, Lisa A. Marzilli, Judith C. Fleming, Astrid M. Kral, Thomas A. Miller, J. Stubbe, Jane M. Sayer and Richard C. Bunt and has published in prestigious journals such as Nucleic Acids Research, Analytical Chemistry and Journal of Chromatography A.

In The Last Decade

Andreas Harsch

16 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Harsch United States 13 228 91 79 60 46 16 345
Yayin Fang United States 12 107 0.5× 107 1.2× 78 1.0× 22 0.4× 18 0.4× 33 310
Xianshu Yang United States 9 264 1.2× 51 0.6× 63 0.8× 31 0.5× 15 0.3× 10 367
Dániel Erös Hungary 13 214 0.9× 60 0.7× 128 1.6× 50 0.8× 12 0.3× 18 426
Dinesh K. Dikshit India 13 224 1.0× 30 0.3× 307 3.9× 33 0.6× 18 0.4× 45 544
Richard T. Blankley United Kingdom 11 306 1.3× 96 1.1× 11 0.1× 26 0.4× 25 0.5× 12 436
Rachel A. Garlish United Kingdom 9 275 1.2× 273 3.0× 38 0.5× 23 0.4× 8 0.2× 10 445
V. M. Shkumatov Belarus 12 192 0.8× 35 0.4× 49 0.6× 53 0.9× 11 0.2× 60 358
Ellen K. Kick United States 9 252 1.1× 12 0.1× 161 2.0× 61 1.0× 32 0.7× 11 385
John Sherrill United States 10 192 0.8× 36 0.4× 213 2.7× 27 0.5× 8 0.2× 15 437
Larry E. Weaner United States 8 187 0.8× 38 0.4× 86 1.1× 15 0.3× 8 0.2× 19 359

Countries citing papers authored by Andreas Harsch

Since Specialization
Citations

This map shows the geographic impact of Andreas Harsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Harsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Harsch more than expected).

Fields of papers citing papers by Andreas Harsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Harsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Harsch. The network helps show where Andreas Harsch may publish in the future.

Co-authorship network of co-authors of Andreas Harsch

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Harsch. A scholar is included among the top collaborators of Andreas Harsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Harsch. Andreas Harsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Haidle, Andrew M., Jason D. Katz, James P. Jewell, et al.. (2016). MARK inhibitors: Declaring a No-Go decision on a chemical series based on extensive DMPK experimentation. Bioorganic & Medicinal Chemistry Letters. 27(1). 109–113. 3 indexed citations
2.
Katz, Jason D., Andrew M. Haidle, James P. Jewell, et al.. (2016). Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(1). 114–120. 13 indexed citations
3.
Deshmukh, Sujal V. & Andreas Harsch. (2010). Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fup/fumic) for refined prediction of phase I mediated metabolic hepatic clearance. Journal of Pharmacological and Toxicological Methods. 63(1). 35–39. 13 indexed citations
4.
Heidebrecht, Richard W., Mélissa Chénard, William K. Dahlberg, et al.. (2009). Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2). Bioorganic & Medicinal Chemistry Letters. 19(7). 2053–2058. 17 indexed citations
5.
Wilson, Kevin J., David J. Witter, Jonathan B. Grimm, et al.. (2008). Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1). Bioorganic & Medicinal Chemistry Letters. 18(6). 1859–1863. 20 indexed citations
6.
Methot, Joey L., Christopher L. Hamblett, Joon Jung, et al.. (2008). SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2). Bioorganic & Medicinal Chemistry Letters. 18(23). 6104–6109. 36 indexed citations
7.
Xu, Lin, et al.. (2008). Identification of Novel Metabolites of Colchicine in Rat Bile Facilitated by Enhanced Online Radiometric Detection. Drug Metabolism and Disposition. 36(4). 731–739. 11 indexed citations
8.
Siliphaivanh, Phieng, Paul E. Harrington, David J. Witter, et al.. (2007). Design of novel histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(16). 4619–4624. 36 indexed citations
9.
Cusack, Kevin P., Lee D. Arnold, Claude Barberis, et al.. (2004). A 13C NMR approach to categorizing potential limitations of α,β-unsaturated carbonyl systems in drug-like molecules. Bioorganic & Medicinal Chemistry Letters. 14(22). 5503–5507. 13 indexed citations
10.
Andrews, Christine L., Andreas Harsch, & Paul Vouros. (2004). Analysis of the in vitro digestion of modified DNA to oligonucleotides by LC–MS and LC–MS/MS. International Journal of Mass Spectrometry. 231(2-3). 169–177. 7 indexed citations
11.
Harsch, Andreas, Lisa A. Marzilli, Richard C. Bunt, J. Stubbe, & Paul Vouros. (2000). Accurate and rapid modeling of iron-bleomycin-induced DNA damage using tethered duplex oligonucleotides and electrospray ionization ion trap mass spectrometric analysis. Nucleic Acids Research. 28(9). 1978–1985. 29 indexed citations
12.
Harsch, Andreas, Jane M. Sayer, Donald M. Jerina, & Paul Vouros. (2000). HPLC−MS/MS Identification of Positionally Isomeric Benzo[c]phenanthrene Diol Epoxide Adducts in Duplex DNA. Chemical Research in Toxicology. 13(12). 1342–1348. 25 indexed citations
13.
Marzilli, Lisa A., et al.. (1999). Oligonucleotide sequencing using guanine-specific methylation and electrospray ionization ion trap mass spectrometry. Journal of Mass Spectrometry. 34(4). 276–280. 17 indexed citations
14.
Andrews, Christine L., Paul Vouros, & Andreas Harsch. (1999). Analysis of DNA adducts using high-performance separation techniques coupled to electrospray ionization mass spectrometry. Journal of Chromatography A. 856(1-2). 515–526. 66 indexed citations
15.
Bendinskas, Kestutis, Andreas Harsch, R. Marshall Wilson, & W. Robert Midden. (1998). Sequence-Specific Photomodification of DNA by an Oligonucleotide-Phenanthrodihydrodioxin Conjugate. Bioconjugate Chemistry. 9(5). 555–563. 12 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026